Details for New Drug Application (NDA): 086826
✉ Email this page to a colleague
NDA 086826 describes ELIXOPHYLLIN SR, which is a drug marketed by Forest Labs and is included in one NDA. Additional details are available on the ELIXOPHYLLIN SR profile page.
The generic ingredient in ELIXOPHYLLIN SR is theophylline. There are thirty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the theophylline profile page.
The generic ingredient in ELIXOPHYLLIN SR is theophylline. There are thirty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the theophylline profile page.
Summary for 086826
| Tradename: | ELIXOPHYLLIN SR |
| Applicant: | Forest Labs |
| Ingredient: | theophylline |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 086826
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 125MG | ||||
| Approval Date: | Jan 29, 1985 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 250MG | ||||
| Approval Date: | Jan 29, 1985 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
